Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1890 (LINC01890) is a member of the lincRNA family, defined as autonomously transcribed non-coding RNAs greater than 200 nucleotides that do not overlap protein-coding genes[1][3][5]. LincRNAs such as LINC01890 typically function in regulation of neighboring gene expression and can act through mechanisms including chromatin remodeling, stabilization of RNA molecules, and direct regulation of transcription; they are often highly tissue-specific and represent a rapidly evolving area in genomics and transcriptome research[5]. To date, no characterized molecular function or disease association has been definitively assigned to LINC01890, and it is not currently classified as a receptor, enzyme, or other conventional drug target[1][3][5][7].
Not applicable; no known drugs target this lincRNA.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1890 (LINC01890).